KR100419478B1 - Anti virus stockings and mehtod for manufacturing the stockings - Google Patents
Anti virus stockings and mehtod for manufacturing the stockings Download PDFInfo
- Publication number
- KR100419478B1 KR100419478B1 KR10-2001-0002749A KR20010002749A KR100419478B1 KR 100419478 B1 KR100419478 B1 KR 100419478B1 KR 20010002749 A KR20010002749 A KR 20010002749A KR 100419478 B1 KR100419478 B1 KR 100419478B1
- Authority
- KR
- South Korea
- Prior art keywords
- socks
- powder
- chitosan
- weight
- concentrated
- Prior art date
Links
- 238000004519 manufacturing process Methods 0.000 title claims abstract description 17
- 230000002155 anti-virotic effect Effects 0.000 title 1
- 229920001661 Chitosan Polymers 0.000 claims abstract description 51
- 239000000843 powder Substances 0.000 claims abstract description 41
- 241000411851 herbal medicine Species 0.000 claims abstract description 27
- 239000000203 mixture Substances 0.000 claims abstract description 21
- 238000000034 method Methods 0.000 claims abstract description 17
- 239000011248 coating agent Substances 0.000 claims abstract description 12
- 239000004480 active ingredient Substances 0.000 claims abstract description 11
- 239000000853 adhesive Substances 0.000 claims abstract description 11
- 230000001070 adhesive effect Effects 0.000 claims abstract description 11
- 230000000845 anti-microbial effect Effects 0.000 claims abstract description 8
- 238000000576 coating method Methods 0.000 claims abstract description 7
- 239000007788 liquid Substances 0.000 claims abstract description 7
- 239000007864 aqueous solution Substances 0.000 claims abstract description 6
- 239000000243 solution Substances 0.000 claims abstract description 6
- 229920003002 synthetic resin Polymers 0.000 claims abstract description 6
- 239000000057 synthetic resin Substances 0.000 claims abstract description 6
- 239000006247 magnetic powder Substances 0.000 claims abstract description 5
- 239000002904 solvent Substances 0.000 claims abstract description 5
- 238000001035 drying Methods 0.000 claims abstract description 4
- 238000010438 heat treatment Methods 0.000 claims abstract description 4
- 238000005245 sintering Methods 0.000 claims abstract description 3
- 239000011247 coating layer Substances 0.000 claims description 8
- 230000000844 anti-bacterial effect Effects 0.000 claims description 5
- 230000001954 sterilising effect Effects 0.000 abstract description 18
- 238000004659 sterilization and disinfection Methods 0.000 abstract description 17
- 230000017531 blood circulation Effects 0.000 abstract description 12
- 239000008280 blood Substances 0.000 abstract description 2
- 210000004369 blood Anatomy 0.000 abstract description 2
- 230000035515 penetration Effects 0.000 abstract description 2
- UQSXHKLRYXJYBZ-UHFFFAOYSA-N Iron oxide Chemical compound [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 description 14
- 230000000694 effects Effects 0.000 description 12
- 210000002683 foot Anatomy 0.000 description 10
- 229920002101 Chitin Polymers 0.000 description 9
- 239000003814 drug Substances 0.000 description 9
- 239000000835 fiber Substances 0.000 description 8
- 239000000463 material Substances 0.000 description 8
- 239000010410 layer Substances 0.000 description 6
- 210000004243 sweat Anatomy 0.000 description 6
- 241000894006 Bacteria Species 0.000 description 5
- 239000000919 ceramic Substances 0.000 description 5
- 201000010099 disease Diseases 0.000 description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
- 239000004615 ingredient Substances 0.000 description 5
- 238000002156 mixing Methods 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- 241000208340 Araliaceae Species 0.000 description 4
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 4
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 4
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 4
- 235000003140 Panax quinquefolius Nutrition 0.000 description 4
- 229940079593 drug Drugs 0.000 description 4
- 235000008434 ginseng Nutrition 0.000 description 4
- 230000036541 health Effects 0.000 description 4
- 230000004060 metabolic process Effects 0.000 description 4
- 238000006386 neutralization reaction Methods 0.000 description 4
- 230000008569 process Effects 0.000 description 4
- 239000002994 raw material Substances 0.000 description 4
- 208000017520 skin disease Diseases 0.000 description 4
- 210000001519 tissue Anatomy 0.000 description 4
- 108090000790 Enzymes Proteins 0.000 description 3
- 102000004190 Enzymes Human genes 0.000 description 3
- 230000001580 bacterial effect Effects 0.000 description 3
- 230000009286 beneficial effect Effects 0.000 description 3
- 239000011230 binding agent Substances 0.000 description 3
- 230000006378 damage Effects 0.000 description 3
- 150000004676 glycans Chemical class 0.000 description 3
- 239000012676 herbal extract Substances 0.000 description 3
- 239000000696 magnetic material Substances 0.000 description 3
- 230000005415 magnetization Effects 0.000 description 3
- 239000002245 particle Substances 0.000 description 3
- 229920001282 polysaccharide Polymers 0.000 description 3
- 239000005017 polysaccharide Substances 0.000 description 3
- 238000007639 printing Methods 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 230000005855 radiation Effects 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 238000005406 washing Methods 0.000 description 3
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Chemical compound CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 description 2
- 235000008733 Citrus aurantifolia Nutrition 0.000 description 2
- 241000238557 Decapoda Species 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 240000002045 Guettarda speciosa Species 0.000 description 2
- 235000001287 Guettarda speciosa Nutrition 0.000 description 2
- 241000238631 Hexapoda Species 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- 235000011941 Tilia x europaea Nutrition 0.000 description 2
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 2
- RAOSIAYCXKBGFE-UHFFFAOYSA-K [Cu+3].[O-]P([O-])([O-])=O Chemical compound [Cu+3].[O-]P([O-])([O-])=O RAOSIAYCXKBGFE-UHFFFAOYSA-K 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 230000004913 activation Effects 0.000 description 2
- 238000001467 acupuncture Methods 0.000 description 2
- 125000003277 amino group Chemical group 0.000 description 2
- 239000004599 antimicrobial Substances 0.000 description 2
- 230000008033 biological extinction Effects 0.000 description 2
- 229910000019 calcium carbonate Inorganic materials 0.000 description 2
- AXCZMVOFGPJBDE-UHFFFAOYSA-L calcium dihydroxide Chemical compound [OH-].[OH-].[Ca+2] AXCZMVOFGPJBDE-UHFFFAOYSA-L 0.000 description 2
- 239000000920 calcium hydroxide Substances 0.000 description 2
- 229910001861 calcium hydroxide Inorganic materials 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 230000004087 circulation Effects 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 230000006196 deacetylation Effects 0.000 description 2
- 238000003381 deacetylation reaction Methods 0.000 description 2
- GHVNFZFCNZKVNT-UHFFFAOYSA-N decanoic acid Chemical compound CCCCCCCCCC(O)=O GHVNFZFCNZKVNT-UHFFFAOYSA-N 0.000 description 2
- 235000013325 dietary fiber Nutrition 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 230000029142 excretion Effects 0.000 description 2
- 235000008216 herbs Nutrition 0.000 description 2
- FUZZWVXGSFPDMH-UHFFFAOYSA-N hexanoic acid Chemical compound CCCCCC(O)=O FUZZWVXGSFPDMH-UHFFFAOYSA-N 0.000 description 2
- 210000000987 immune system Anatomy 0.000 description 2
- 239000004571 lime Substances 0.000 description 2
- 230000007721 medicinal effect Effects 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- 238000000465 moulding Methods 0.000 description 2
- 239000005416 organic matter Substances 0.000 description 2
- 230000035699 permeability Effects 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 239000008247 solid mixture Substances 0.000 description 2
- 230000000638 stimulation Effects 0.000 description 2
- 238000007920 subcutaneous administration Methods 0.000 description 2
- BWMISRWJRUSYEX-SZKNIZGXSA-N terbinafine hydrochloride Chemical compound Cl.C1=CC=C2C(CN(C\C=C\C#CC(C)(C)C)C)=CC=CC2=C1 BWMISRWJRUSYEX-SZKNIZGXSA-N 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 201000004647 tinea pedis Diseases 0.000 description 2
- 229940124594 traditional oriental medicine Drugs 0.000 description 2
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 description 1
- XYHKNCXZYYTLRG-UHFFFAOYSA-N 1h-imidazole-2-carbaldehyde Chemical compound O=CC1=NC=CN1 XYHKNCXZYYTLRG-UHFFFAOYSA-N 0.000 description 1
- GWYFCOCPABKNJV-UHFFFAOYSA-M 3-Methylbutanoic acid Natural products CC(C)CC([O-])=O GWYFCOCPABKNJV-UHFFFAOYSA-M 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- 229910021532 Calcite Inorganic materials 0.000 description 1
- 239000005632 Capric acid (CAS 334-48-5) Substances 0.000 description 1
- 229910052684 Cerium Inorganic materials 0.000 description 1
- 241000931705 Cicada Species 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- 241000238424 Crustacea Species 0.000 description 1
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 235000016257 Mentha pulegium Nutrition 0.000 description 1
- 244000246386 Mentha pulegium Species 0.000 description 1
- 235000004357 Mentha x piperita Nutrition 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- LSDPWZHWYPCBBB-UHFFFAOYSA-N Methanethiol Chemical compound SC LSDPWZHWYPCBBB-UHFFFAOYSA-N 0.000 description 1
- 229910052779 Neodymium Inorganic materials 0.000 description 1
- 241000238814 Orthoptera Species 0.000 description 1
- 229910052772 Samarium Inorganic materials 0.000 description 1
- 241000130993 Scarabaeus <genus> Species 0.000 description 1
- 239000005708 Sodium hypochlorite Substances 0.000 description 1
- 102000004142 Trypsin Human genes 0.000 description 1
- 108090000631 Trypsin Proteins 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 229910021536 Zeolite Inorganic materials 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000037374 absorbed through the skin Effects 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 210000003423 ankle Anatomy 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 230000003906 autonomic nervous system functioning Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- GWYFCOCPABKNJV-UHFFFAOYSA-N beta-methyl-butyric acid Natural products CC(C)CC(O)=O GWYFCOCPABKNJV-UHFFFAOYSA-N 0.000 description 1
- 230000036760 body temperature Effects 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 230000000747 cardiac effect Effects 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- GWXLDORMOJMVQZ-UHFFFAOYSA-N cerium Chemical compound [Ce] GWXLDORMOJMVQZ-UHFFFAOYSA-N 0.000 description 1
- 108010089807 chitosanase Proteins 0.000 description 1
- RQFQJYYMBWVMQG-IXDPLRRUSA-N chitotriose Chemical compound O[C@@H]1[C@@H](N)[C@H](O)O[C@H](CO)[C@H]1O[C@H]1[C@H](N)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)N)[C@@H](CO)O1 RQFQJYYMBWVMQG-IXDPLRRUSA-N 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 229910017052 cobalt Inorganic materials 0.000 description 1
- 239000010941 cobalt Substances 0.000 description 1
- GUTLYIVDDKVIGB-UHFFFAOYSA-N cobalt atom Chemical compound [Co] GUTLYIVDDKVIGB-UHFFFAOYSA-N 0.000 description 1
- VQVNCTNULYBZGL-UHFFFAOYSA-N cobalt yttrium Chemical compound [Co].[Y] VQVNCTNULYBZGL-UHFFFAOYSA-N 0.000 description 1
- 230000001877 deodorizing effect Effects 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 102000038379 digestive enzymes Human genes 0.000 description 1
- 108091007734 digestive enzymes Proteins 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- HNPSIPDUKPIQMN-UHFFFAOYSA-N dioxosilane;oxo(oxoalumanyloxy)alumane Chemical compound O=[Si]=O.O=[Al]O[Al]=O HNPSIPDUKPIQMN-UHFFFAOYSA-N 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 229920001971 elastomer Polymers 0.000 description 1
- 239000003623 enhancer Substances 0.000 description 1
- 238000006911 enzymatic reaction Methods 0.000 description 1
- 230000002964 excitative effect Effects 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 239000002657 fibrous material Substances 0.000 description 1
- 239000010419 fine particle Substances 0.000 description 1
- -1 for example Chemical class 0.000 description 1
- 239000010437 gem Substances 0.000 description 1
- 229910001751 gemstone Inorganic materials 0.000 description 1
- 239000000380 hallucinogen Substances 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 229910001385 heavy metal Inorganic materials 0.000 description 1
- 235000001050 hortel pimenta Nutrition 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 239000010977 jade Substances 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 230000005389 magnetism Effects 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 229940041616 menthol Drugs 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- QEFYFXOXNSNQGX-UHFFFAOYSA-N neodymium atom Chemical compound [Nd] QEFYFXOXNSNQGX-UHFFFAOYSA-N 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 210000002569 neuron Anatomy 0.000 description 1
- 125000001400 nonyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 229920001542 oligosaccharide Polymers 0.000 description 1
- 150000002482 oligosaccharides Chemical class 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 239000003973 paint Substances 0.000 description 1
- 230000003071 parasitic effect Effects 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 239000000941 radioactive substance Substances 0.000 description 1
- 229910052761 rare earth metal Inorganic materials 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 239000005060 rubber Substances 0.000 description 1
- KZUNJOHGWZRPMI-UHFFFAOYSA-N samarium atom Chemical compound [Sm] KZUNJOHGWZRPMI-UHFFFAOYSA-N 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 150000003384 small molecules Chemical class 0.000 description 1
- 238000002791 soaking Methods 0.000 description 1
- SUKJFIGYRHOWBL-UHFFFAOYSA-N sodium hypochlorite Chemical compound [Na+].Cl[O-] SUKJFIGYRHOWBL-UHFFFAOYSA-N 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 239000004575 stone Substances 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 229920003051 synthetic elastomer Polymers 0.000 description 1
- 229920002994 synthetic fiber Polymers 0.000 description 1
- 239000005061 synthetic rubber Substances 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 239000012588 trypsin Substances 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
- 239000002759 woven fabric Substances 0.000 description 1
- 239000010457 zeolite Substances 0.000 description 1
- 239000011787 zinc oxide Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A41—WEARING APPAREL
- A41B—SHIRTS; UNDERWEAR; BABY LINEN; HANDKERCHIEFS
- A41B11/00—Hosiery; Panti-hose
-
- A—HUMAN NECESSITIES
- A41—WEARING APPAREL
- A41B—SHIRTS; UNDERWEAR; BABY LINEN; HANDKERCHIEFS
- A41B11/00—Hosiery; Panti-hose
- A41B11/005—Hosiery made essentially of a multi-ply construction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N2005/0658—Radiation therapy using light characterised by the wavelength of light used
- A61N2005/0659—Radiation therapy using light characterised by the wavelength of light used infrared
- A61N2005/066—Radiation therapy using light characterised by the wavelength of light used infrared far infrared
Landscapes
- Engineering & Computer Science (AREA)
- Textile Engineering (AREA)
- Socks And Pantyhose (AREA)
- Medicinal Preparation (AREA)
- Radiation-Therapy Devices (AREA)
Abstract
본 발명은 항균양말 및 그의 제조방법에 관한 것으로서, 더욱 구체적으로는 한약재, 키토산, 및 원적외선을 발산하는 물질을 함유함으로서 한약재의 유효성분의 피부침투, 혈액순환촉진, 살균기능하여 신체하부의 혈액순환을 촉진하고 양말이나 신발에서 발생되는 악취 제거 및 살균을 제거할 수 있는 양말 및 그의 제조방법에 관한 것이다.The present invention relates to antimicrobial socks and a method for manufacturing the same, and more specifically, herbal medicine, chitosan, and containing far-infrared rays, which involve the skin penetration, blood circulation, and sterilization of the active ingredients of the herbal medicine to circulate blood in the lower body. It relates to a sock and a method for manufacturing the same that can promote and eliminate the odor and sterilization generated in socks or shoes.
본 발명에 의한 양말 및 그의 제조방법은, 한약재로부터 특정유효성분을 액상 및 분말상으로 제조하는 제1단계와; 수용성키토산을 수용액에 용해시키고 불용성 키토산분말을 제조하는 제2단계와; 상기 단계에서 생성된 한약재 액상유효성분과 키토산수용액을 혼화한 용액에 양말을 침지시키고 자연 또는 히터가열에 의하여 건조시키는 제3단계와; 상기 단계에서 제조된 한약재분말상을 입자상태로 농축시켜 분쇄하고, 한약재의 농축분말과 키토산농축분말의 중량비 10%와, 코팅제 중량비15%와, 용제 중량비 75%정도로 묽게 혼화하여 제3단계에서 건조된 양말에 코팅하는 제4단계와; 상기 코팅된 양말을 히터를 이용하여 소결시키는 제5단계와; 상기 제5단계에서 소결된 양말에 미세 분말상의 원적외선 방사체 중량비 25%와, 미세 분말상의 자성체 중량비 25%와, 합성수지 접착제 중량비 50%로 혼화하여 약 0.3-3mm 정도의 두께, 폭3-10mm 정도로 조성물을 돌기형태로 형성하는 제6단계와; 조성물 돌기에 열을 가하여 양말의 내표면에 접착시키는 제7단계를 포함한다.Socks and a method for producing the same according to the present invention comprises the first step of producing a specific active ingredient from the herbal medicine in liquid and powder form; Dissolving the aqueous chitosan in an aqueous solution and preparing an insoluble chitosan powder; A third step of immersing the socks in a solution mixed with the herbal active ingredient and chitosan aqueous solution produced in the step and drying by natural or heater heating; The medicinal herb powder phase prepared in the above step was concentrated and pulverized, and the mixture was thinly mixed with 10% by weight of the concentrated powder and chitosan concentrated powder, 15% by weight of the coating agent and 75% by weight of the solvent, and dried in the third step. A fourth step of coating the socks; A fifth step of sintering the coated socks using a heater; The socks sintered in the fifth step were mixed with 25% by weight of the far-infrared radiator of fine powder, 25% by weight of the magnetic powder of fine powder, and 50% by weight of synthetic resin adhesive, and the composition was about 0.3-3 mm thick and 3-10 mm wide. Forming a protrusion in the form of a protrusion; And a seventh step of applying heat to the composition protrusions to bond the inner surface of the sock.
Description
본 발명은 항균양말 및 그의 제조방법에 관한 것으로서, 더욱 구체적으로는 한약재, 키토산, 및 원적외선을 발산하는 물질을 함유함으로서 한약재의 유효성분의 피부침투, 혈액순환촉진, 살균기능하여 신체하부의 혈액순환을 촉진하고 양말이나 신발에서 발생되는 악취 제거 및 살균을 제거할 수 있는 양말 및 그의 제조방법에 관한 것이다.The present invention relates to antimicrobial socks and a method for manufacturing the same, and more specifically, herbal medicine, chitosan, and containing far-infrared rays, which involve the skin penetration, blood circulation, and sterilization of the active ingredients of the herbal medicine to circulate blood in the lower body. It relates to a sock and a method for manufacturing the same that can promote and eliminate the odor and sterilization generated in socks or shoes.
발을 보호하기 위하여 착용되는 양말은 합성섬유 또는 면섬유를 주재료로 하여 제조된다. 양말을 착용함으로써 발에서 나는 땀을 흡수하고 외부의 충격으로부터 보호하는 순기능을 가지고 있다. 그러나 현대인들은 하루종일 양말을 신고 생활을 하기 때문에 이로 인한 역기능이 발생된다. 다시말하면, 양말을 신은 상태에서 하루종일 구두, 운동화등을 신고 생활하기 때문에 양말에 흡수된 땀이 양말이나 신발에 기생하는 바이러스에 의하여 무좀, 습진등과 같은 피부질환을 유발시키고 악취가 발생된다. 따라서 양말을 착용하는 것이 생활화된 상태에서 양말에 의한 피부질환을 방지하기 어려운 문제점이 있다.Socks worn to protect the foot are made from synthetic or cotton fibers as the main material. By wearing socks, your feet absorb sweat and protect it from external shocks. However, modern people live wearing socks all day long, which causes dysfunction. In other words, wearing socks, sneakers, etc. all day while wearing socks, sweat absorbed by the socks causes skin diseases such as athlete's foot, eczema, etc. by the parasitic virus in socks or shoes, and odor is generated. Therefore, there is a problem in that wearing socks is difficult to prevent skin diseases caused by socks in the state of living.
이러한 문제점을 해결하기 위하여, 신발의 밑창에 통풍이 잘되는 구조를 형성하기도 하고, 양말의 냄새를 제거하기 위한 성분을 함유한 양말이 제조, 판매되고 있다. 양말의 냄새제거에 사용되는 성분은, 예를 들어 구리분말등과 같은 여러종류의 화합물이다.In order to solve such a problem, a sock that forms a well-ventilated structure on the sole of the shoe, and socks containing the ingredients for removing the smell of the socks are manufactured and sold. The components used for deodorizing socks are various kinds of compounds such as, for example, copper powder.
또한 땀에 의한 발냄새제거뿐만 아니라, 발의 혈액순환을 원활하게 하도록 자성을 띤 물질이 혼합된 혼합물을 PVC등의 접착물을 이용하여 다수의 돌기를 형성하여 양말을 착용한 상태에서 활동하도록 구성하기도 한다.In addition to the removal of foot odor by sweat, the mixture of magnetic materials to facilitate the blood circulation of the foot is formed by using a adhesive such as PVC to form a plurality of protrusions to be active while wearing socks. do.
전통동양의학의 경락(經絡) 지식에 기초하여 양말에 형성되는 지압돌기들은 발에 분포된 경혈들을 자극하여 인체에 기를 유통시킴으로서 인체내부의 장기들의 활동에 도움을 주며, 이에 따라서 신체의 건강성을 유지한다.Acupressure protrusions formed on socks based on Meridian knowledge of traditional Oriental medicine help stimulate the acupuncture points distributed on the foot and distribute them to the human body, thus helping the organs in the human body. Keep it.
양말에 지압용 돌기를 형성한 기술이 공지되어 있다. 예를 들어서 양말의 바닥면에 다수의 돌기를 형성한 것으로서는 일본공개실개소49-94895호, 및 국내공개 특허 제89-1258호를 비롯하여, 특허공고 제89-5198호에는 지압작용과 동시에 살균, 혈류촉진 및 악취중화 작용이 이루어지도록 돌기부분에 차아염소산나트륨, 자석화 분말, 동분을 함유한 양말이 개시되어 있다.Techniques for forming acupressure protrusions on socks are known. For example, the number of protrusions formed on the bottom of a sock includes Japanese Patent Application Laid-Open No. 49-94895 and Domestic Publication No. 89-1258, and Patent Publication No. 89-5198 sterilizes simultaneously with acupressure. A sock containing sodium hypochlorite, magnetized powder, and copper powder in a protruding portion to promote blood flow and odor neutralization is disclosed.
또다른 기술로서, 상기의 기술을 바탕으로한 특허공고 제 89-5198호를 개량시켜 개발한 '건강을 돕는 양말의 제조방법 및 양말바닥 혼착층 구조로 공고된 특허공고 제 92-9406호'와 '피부자극용 한약 및 자석 함유물로 공고된 특허공고 제 94-8968호'가 양말바닥에 돌기를 형성하여 접착된 상태로 사용되고 있다.As another technique, the patent publication No. 92-9406, which was developed by improving the patent publication No. 89-5198 based on the above technology, and the manufacturing method of the socks for health and the socks bottom mixed layer structure, and Patent Publication No. 94-8968, published as a herbal medicine for skin stimulation and a magnetic substance, is used in a state in which a protrusion is formed on the bottom of a sock.
상기한 특허공고 제 92-9406호는 양말바닥면에 침투시키는 혼합물내에 세라믹분말, 수산화칼슘, 탄산칼슘, 린산동 및 극미량의 노닐산바닐아미드, 멘톨, 산화아연을 혼합, 첨가하여 살균작용, 혈류촉진, 악취중화작용과 함께 응결력을 보강하는 고무와 자력을 갖도록 산화철을 함유시켜 양말바닥의 내외면으로 돌출되지 않고 조직사이에 침투시켜 발바닥이 약한사람에게 중증없이 지압작용과 함께 살균, 혈류촉진, 악취중화 작용을 할 수 있게 구성되어 있다.Patent Publication No. 92-9406 discloses sterilization and blood flow by mixing and adding ceramic powder, calcium hydroxide, calcium carbonate, copper phosphate and trace amounts of nonyl nilamide, menthol, and zinc oxide in a mixture that penetrates the bottom of a sock. It contains rubber to reinforce cohesion and odor neutralization, and iron oxide to have magnetic force. It does not protrude into the inner and outer surfaces of the socks but penetrates between tissues. It is configured to be neutralized.
상기 발명에서 원적외선에 의한 혈류를 촉진시키기 위한 소량의 세라믹분말과 냄새제거와 살균작용이 이루어지도록 수산화칼슘, 탄산칼슘, 린산동 등과 자성을 갖도록 산화철 그리고 접착을 위한 합성수지와 고무등을 혼화하여 양말바닥에 접착시켜 사용하고 있으나 상기 조성물의 농도가 너무 희박하여 소기의 효과를 거두기가 매우 곤란하도록 되어 있다.In the present invention, a small amount of ceramic powder to promote blood flow by far-infrared rays and iron oxide to have magnetic properties such as calcium hydroxide, calcium carbonate, copper phosphate to remove odor and sterilization, and a synthetic resin and rubber for adhesion to socks bottom Although it is used by bonding, the concentration of the composition is so thin that it is very difficult to achieve the desired effect.
즉, 원적외선이나 자력은 장애물의 투과가 가능하나, 살균과 악취의 중화 내지 소멸에 있어 소재와 세균이 직접 접촉이되지 않게 되면 살균작용과 악취의 발생을 막을 수 없게 되는데, 조성물에서 살균작용과 악취의 발생을 막는 소재의 효과도 미약할 뿐만 아니라 농도가 희박하여 실질적으로 살균과 악취발생을 방지할 수 없는 문제점이 발생된다.That is, far infrared rays or magnetic force can penetrate obstacles, but when the material and bacteria are not in direct contact with each other in neutralization or extinction of sterilization and odor, sterilization and odor cannot be prevented. In addition to the weak effect of the material to prevent the occurrence of a thinner concentration is a problem that can not substantially prevent the generation of sterilization and odor.
그리고, 피부자극용 한약 및 자석 함유물로 공고된 특허공고 제 94-8968호의 경우에도 일반 직조물이나 지류보다 상기와같이 주로 양말에 많이 사용하고 있는 것으로, 한약에 약한 자극과 자력에 의한 치료를 동시에 할 수 있는 한약과 자석분을 바인더로 고형화한 것이다.In addition, in the case of Patent Publication No. 94-8968, which is announced as a herbal medicine for skin stimulation and a magnet-containing substance, it is mainly used in socks as described above than a general woven fabric or a tributary. Chinese medicine and magnet powder can be solidified with a binder.
상기 발명에서 자력과 약물의 약효 발휘하도록 고형조성물을 제조하여 이 조 성물로 인체의 피부 및 근육을 자극하여 질병의 치료와 건강을 증진하는 고형 조성물로 자석분과 인체의 질병치료용 또는 건강증진용 한약재와 세라믹, 동분 및 몰딩바인더로 구성하여 이에 외부로부터 자력을 주입하여 제조된다.In the present invention, by preparing a solid composition to exert the magnetic force and the medicinal effect of the drug to stimulate the skin and muscles of the human body with this composition as a solid composition for promoting the treatment and health of the disease as a magnetic powder for the treatment or health promotion of the human body Composed of a ceramic, copper powder and molding binder and is manufactured by injecting magnetic force from the outside.
이 기술 역시 상기와 같이 원적외선에 의한 혈류를 촉진시키기 위한 세라믹분 5-15%,과 질병치료를 위하여 당귀, 천궁, 청향, 환각향, 용의, 고맥반, 박하, 유근피, 해엽, 백지, 계피, 규석, 세신, 인삼, 등으로 이루어진 혼합율10-20%인 한약재와 살균과 냄새제거를 위한 미세동분5-15%, 그리고 자석분20-60%, 접착제로 몰딩바인더50-60%의 용량비로 이루어진 조성물로 혼화하여 양말바닥에 접착시켜 사용하고 있으나 이 역시 상기 조성물의 농도가 너무 희박하여 소기의 효과를 거두기가 매우 곤란하도록 되어 있으며, 또한 제조하기가 어려운 문제점이 있다.This technique also uses 5-15% of ceramic powder to promote blood flow by far-infrared rays, and Angelica, Cheongung, Cheonghyang, Hallucinogen, Dragon's head, Macula, Mint, Yu Geun-pi, Sea Leaf, White Paper, Cinnamon With the mixing ratio of 10-20% of Chinese medicine, silica, sessin, ginseng, etc., 5-15% of fine copper powder for sterilization and odor removal, 20-60% of magnetic powder, and 50-60% molding binder with adhesive It is mixed with the composition consisting of a sock to the bottom of the composition is used, but it is also very difficult to achieve the desired effect because the concentration of the composition is too thin, there is also a problem that is difficult to manufacture.
즉, 세라믹의 경우 소량으로 원적외선의 방출률이 그다지 높지 않으며, 혼화된 한약재도 접착제에 몰딩된 상태에서 원 재료를 그대로 사용하므로 미소한 양이 인체에 접촉으로 질병을 치유한다는 것은 효과를 기대하기는 곤란할 수밖에 없으며, 동분 역시 상기와 같은 문제점들을 살균과 악취의 중화 내지 소멸에 있어 상기와 같이 미소한 항균 소재와 세균이 직접접촉이 되지 않게 되면 항균소재의 살균작용과 악취의 발생을 막을 수 없게 된다.In other words, in the case of ceramics, the emission rate of far-infrared rays is not very high in small amounts, and even mixed herbs are used as raw materials in the state of being molded in adhesive, so it is difficult to expect the effect to heal the disease by the minute amount coming into contact with the human body. In addition, the same powder can also prevent the sterilization of the antimicrobial material and the generation of odor if the microbial material and bacteria are not in direct contact with the above problems in neutralization or extinction of sterilization and odor.
따라서 상기한 조성물에서 살균작용과 악취의 발생을 막는 소재의 농도가 희박하여 실질적으로 살균과 악취발생을 방지할수 없으며, 한약에 의한 질환치료 역시 미흡할 수밖에 없는 문제점이 있다.Therefore, the concentration of the material that prevents the sterilization action and the occurrence of odor in the composition can not substantially prevent the sterilization and odor generation, there is a problem that the treatment of diseases caused by Chinese medicine also has to be insufficient.
더욱이 상기한 양말들에서는 지압돌기가 주로 양말의 바닥면에 형성됨으로서 발바닥과의 마찰로 인하여 돌기의 파손율이 높아지고, 세탁시에도 파손이 잘되는 문제점이 있다.Furthermore, in the socks, the acupressure protrusion is mainly formed on the bottom surface of the sock, and thus the breakage rate of the protrusion is increased due to friction with the sole of the sock, and there is a problem in that the breakage is good even when washing.
본 발명은 상기한 문제점 해결하기 위한 것으로서, 그 목적은 지압효과와 함께 원적외선 발산 및 키토산에 의한 살균기능과 한약재의 유효성분침투특성을 가짐으로서 신체 하부의 혈액순환을 촉진하고 양말이나 신발에서 발생되는 악취 제거 및 살균을 제거할 수 있는 항균양말 및 그의 제조방법을 제공하는데 있다.The present invention is to solve the above problems, its purpose is to promote blood circulation of the lower body by having a sterilizing function by far-infrared radiation and chitosan and effective minute permeation characteristics of the herbal medicine with the effect of acupressure and is generated in socks or shoes It is to provide an antibacterial socks and a method for manufacturing the same that can remove the odor and sterilization.
본 발명의 다른 목적은, 양말착용시 살균기능이 개선되어 세균에 의한 악취발생방지 및 피부질환의 예방에 도움이 되며, 발바닥과의 마찰에 의한 파손 및 세탁시의 파손율을 감소시켜 내구성이 개선된 항균양말 및 그의 제조방법을 제공하는데 있다.Another object of the present invention is to improve the disinfection function when wearing socks to help prevent the occurrence of odor caused by bacteria and skin diseases, and to reduce the damage caused by friction with the sole of the foot and the damage during washing to improve durability To provide an antibacterial socks and a method for producing the same.
본 발명의 또다른 목적은 양말에 함유된 한약재성분이 지속적으로 배출되더피부를 통하여 인체에 흡수됨으로서 피부질환의 예방 및 건강증진에 일익을 담당할 수 있는 항균양말 및 그의 제조방법을 제공하는데 있다.Still another object of the present invention is to provide an antimicrobial sock and a method for producing the same, which can play a role in the prevention of skin diseases and health promotion by being absorbed by the human body through the skin while the herbal ingredients contained in the socks are continuously discharged.
상기 목적을 달성하기 위한 본 발명은, 한약재 추출체 및 키토산을 접착재와 혼화하여 이루어진 조성물이 형성되고, 원적외선발산 조성물을 이용하여 양말의 바닥에 지압기능을 하도록 다수개의 자력을 갖는 돌기를 형성하여 이루어지도록 한 양말과 그의 제조방법에 있어서, 한약재로부터 특정유효성분을 액상 및 분말상으로 제조하는 제1단계와, 수용성키토산을 수용액에 용해시키고 불용성 키토산분말을 제조하는 제2단계와, 상기 단계에서 생성된 한약재 액상유효성분과 키토산수용액을 혼화한 용액에 양말을 침지시키고 자연 또는 히터가열에 의하여 건조시키는 제3단계; 상기 단계에서 제조된 한약재분말상을 입자상태로 농축시켜 분쇄하고, 한약재의 농축분말과 키토산농축분말의 중량비 10%와, 코팅제 중량비15%와, 용제 중량비 75%정도로 묽게 혼화하여 제3단계에서 건조된 양말에 코팅하는 제4단계와, 상기 코팅된 양말을 히터를 이용하여 소결시키는 제5단계; 상기 제5단계에서 소결된 양말에 미세 분말상의 원적외선 방사체 중량비 25%와, 미세 분말상의 자성체 중량비 25%와, 합성수지 접착제 중량비 50%로 혼화하여 약 0.3-3mm 정도의 두께, 폭3-10mm 정도로 조성물을 돌기형태로 형성하는 제6단계와, 조성물 돌기에 열을 가하여 양말의 내표면에 접착시키는 제7단계를 포함하는 것을 특징으로 한다.The present invention for achieving the above object is formed by mixing the herbal medicine extract and chitosan with an adhesive material is formed, by forming a plurality of projections having a magnetic force to function as a pressure on the bottom of the socks using the far-infrared radiation composition In the socks and its manufacturing method, the first step of preparing a specific active ingredient in liquid and powder form from the herbal medicine, the second step of dissolving the water-soluble chitosan in an aqueous solution to prepare an insoluble chitosan powder, A third step of immersing the socks in a solution in which the herbal active ingredient and chitosan aqueous solution are mixed and drying by natural or heater heating; The medicinal herb powder phase prepared in the above step was concentrated and pulverized, and the mixture was thinly mixed with 10% by weight of the concentrated powder and chitosan concentrated powder, 15% by weight of the coating agent and 75% by weight of the solvent, and dried in the third step. A fourth step of coating the socks, and a fifth step of sintering the coated socks using a heater; The socks sintered in the fifth step were mixed with 25% by weight of the far-infrared radiator of fine powder, 25% by weight of the magnetic powder of fine powder, and 50% by weight of synthetic resin adhesive, and the composition was about 0.3-3 mm thick and 3-10 mm wide. And a sixth step of forming a protrusion in the form of a protrusion, and applying a heat to the composition protrusion to bond it to the inner surface of the sock.
도 1은 본 발명에 의한 돌기가 형성된 양말의 구성도,1 is a block diagram of a sock formed projection according to the present invention,
도 2는 도 1의 돌기부분의 확대단면도,2 is an enlarged cross-sectional view of the protrusion of FIG.
도 3은 본 발명의 방법을 수행하기 위한 흐름도.3 is a flow chart for carrying out the method of the present invention.
도 4는 본 발명에 의한 돌기의 변형예를 나타내는 사시도.4 is a perspective view showing a modification of the projection according to the present invention.
※도면의 주요부분에 대한 부호의 설명※※ Explanation of symbols about main part of drawing ※
1 : 양말 2 : 지압돌기1: socks 2: acupressure protrusions
2a: 돌기부 2b: 함몰부2a: protrusion 2b: depression
3 : 섬유 4 : 피막층3: fiber 4: coating layer
5 : (원적외선방사) 조성물5: (far infrared radiation) composition
이하 첨부된 도면을 참고하여 본 발명의 살균기능을 가진 양말 및 그의 제조방법을 설명하면 다음과 같다.Hereinafter, referring to the accompanying drawings, a sock having a sterilizing function and a method of manufacturing the same will be described below.
본 발명은 양말의 원료가 되는 섬유재질에 한약재 및 키토산성분을 2중으로 형성하며, 특히 외각에 형성되는 한약재 및 키토산성분층을 코팅시킴으로서, 발바닥에 의한 충격 및 세탁에 의한 충격으로부터 장시간 유지되는 효과가 있으며, 또한 원적외선을 방사하는 돌기구조물을 형성한 항균양말 및 그에 제조방법에 관한 것이다.The present invention forms a double medicinal herb and chitosan component in the fiber material that is the raw material of the socks, and in particular, by coating the herbal and chitosan component layer formed on the outer shell, the effect that is maintained for a long time from the impact of the soles and the impact of washing The present invention also relates to an antimicrobial sock and a method of manufacturing the same, which form a protrusion structure emitting far infrared rays.
도 1은 본 발명에 의한 양말로서, 양말(1)의 바닥면에 다수의 돌기(2)가 형성되어 있으며, 도 2에 돌기(2)의 상세한 구조가 표시되어 있다. 상기 돌기(2)들은 양말을 뒤집은 상태에서 바닥의 일부면 또는 양말의 전체면에 걸쳐서 일정한 간격으로 형성시킨다. 따라서 전체면에 걸쳐서 형성된 경우에는 발바닥뿐만 아니라 발목 부분에도 효과가 있다.1 is a sock according to the present invention, a plurality of protrusions (2) are formed on the bottom surface of the sock (1), the detailed structure of the protrusion (2) is shown in FIG. The protrusions 2 are formed at regular intervals over a part of the bottom or the entire surface of the socks while the socks are turned upside down. Therefore, when formed over the entire surface is effective for the ankle part as well as the sole.
우선 본 발명의 방법을 단계별로 설명하면 다음과 같다.First, the method of the present invention will be described step by step.
제1단계에서는 인체에 필요한 성분을 포함하는 한약재를 선별한다. 인체에 유해하지 않고 사용할 수 있는 일반적으로 알려진 한약재로는 당귀, 천궁, 박하, 백지, 계피, 세신, 인삼 등이 있다. 인삼은 특히 직접 또는 끓여서 복용할 수 있으며, 피부를 통하여 흡수되는 성분이 포함됨은 널리 알려져 있다.In the first step, herbal medicines containing ingredients necessary for the human body are selected. Commonly known herbs that can be used without harm to the human body include Angelica, Cheongung, Peppermint, White Paper, Cinnamon, Sessin and Ginseng. Ginseng can be taken in particular, either directly or by boiling, and it is widely known that ginseng contains ingredients that are absorbed through the skin.
물론 특정목적을 위하여 그에 상응하는 효용을 가진 약재들을 선택할 수 있다. 따라서 무좀에 유용한 한약재, 또는 기력회복등에 유용한 한약재등을 포함하는 특수목적의 양말의 제조가 가능하다. 상기의 약재들은 약전에 따라서 처방에 따라가감하거나 추가하여 에타놀에 침지시키거나, 또는 물에 넣고 끓여 유효성분을 액상으로 추출한다. 또한 본 발명에서는 추출된 유효성분들을 분말상으로도 제조하여 준비한다.Of course, for certain purposes, you can choose the medicines with the corresponding utility. Therefore, it is possible to manufacture socks for special purposes, including herbal medicine useful for athlete's foot, or herbal medicine useful for energy recovery. According to the pharmacopeias, the above medicines are added or subtracted according to the prescription, soaked in ethanol, or boiled in water to extract the active ingredient in liquid form. In addition, the present invention is prepared by preparing the extracted active ingredients in powder form.
상기와 같이 한약재로부터 유효성분을 액상, 분말상으로 추출한 후에, 제2단계로서 키토산을 역시 액상 및 분말상으로 제조한다. 키토산의 액상 및 분말상 제조는 키토산의 수용성, 불용성에 따른 성질을 이용하여 용이하게 제조할 수 있다.After extracting the active ingredient from the herbal medicine in the liquid, powder form as described above, chitosan is also prepared in the liquid and powder form as a second step. Liquid and powdery preparation of chitosan can be easily prepared using the properties of water solubility and insolubility of chitosan.
먼저 키토산의 특징을 설명하면 다음과 같다.First, the characteristics of chitosan are described.
키토산이란, 키틴으로부터 추출된 천연다당류를 의미한다. 키틴이란 가제, 게, 새우와 같은 갑각류와 풍뎅이, 매미, 메뚜기와 같은 곤충의 외피 버섯이나 미생물의 세포막에 존재하는 천연다당류로서 이것으로부터 정제과정(탈아세틸과정)을 거쳐 키틴, 키토산, 그리고 키토 올리고당을 얻는다.Chitosan means the natural polysaccharide extracted from chitin. Chitin is a natural polysaccharide that exists in shells of insects such as gauze, crabs and shrimps, and in the shells of insects such as scarabs, cicada and locusts, and from the membranes of microorganisms. The chitin, chitosan, and chito oligosaccharides are purified from this process. Get
일반적으로 갑각류중 특히 홍게 껍질(다리부분)을 원료로 사용하는데 그 이유는 자연계에서 키틴질을 많이 함유하고 있기 때문이다. 여기에는 키틴질, 석회질, 단백질이 각각 1/3정도 함유되어 있고, 석회질과 단백질을 제거하여 순수한 키틴을 추출하고 이를 원료로 하여 정제 과정인 탈 아세틸공정을 거쳐서 키토산을 얻는다.In general, crustaceans, especially red crab shells (legs), are used as raw materials because they contain a lot of chitin in nature. It contains about one-third of chitin, lime, and protein, and it removes lime and protein to extract pure chitin and uses it as a raw material to obtain chitosan through a deacetylation process.
고분자 다당류인 키토산에 분해효소(라미소자임, 키토사나아제등)를 넣어 효소 반응을 시켜 저분자화 함으로써 극저분자인 키토산 올리고당을 얻는다. 셀룰로이즈(식물성 식이섬유)와 분자구조가 아주 유사한 동물성 식이섬유인 키틴, 키토산은 다른 식물성 식이섬유가 가지고 있는 여러 특질을 보유하면서 아주 독특한 특성을 가지고 있다.Chitosan oligosaccharides, which are extremely low molecular weights, are obtained by enzymatic reaction of chitosan, a polymer polysaccharide, by adding enzymes such as lamisozyme and chitosanase. Animal dietary fibers, chitin and chitosan, which have very similar molecular structure to cellulose (vegetable dietary fiber), have unique characteristics while retaining many of the characteristics of other plant fiber.
키틴으로부터 탈 아세틸 과정을 거쳐 얻은 키토산은 아미노기(NH2+)를 갖게 됨으로서 음(-)이온을 가진 물질과 이온 결합을 한다. 용해가 어려운 키틴과 달리 아미노기를 가진 키토산은 비록 물이나 알칼리에는 용해되지 않지만 산에는 쉽게 용해되며, 극저분자인 키토산 올리고당은 물에도 쉽게 용해되는 특성을 가지고 있으며 인체에 쉽게 흡수된다. 이러한 성질을 이용하여 수용성 키토산과 불용성 키토산을 얻을 수 있다.Chitosan obtained through the deacetylation process from chitin has an amino group (NH2 +), thereby ionic bonding with a substance having a negative ion. Unlike chitin, which is difficult to dissolve, chitosan with an amino group is easily soluble in acid, although it is not soluble in water or alkali, and extremely small molecule chitosan oligosaccharide is easily soluble in water and easily absorbed by the human body. By using these properties, water-soluble chitosan and insoluble chitosan can be obtained.
상기와 같은 키토산은 콜레스테롤 조절기능을 가지므로 동맥경화, 심장병등 순환기 질환을 예방하는 효과가 있다. 또한 면역력증강기능을 가지므로 체내에 면역계를 활성화시켜 면역력을 증강시킨다. 또한 살균, 항균작용을 가지므로 미생물의 세포막과 결합하여 미생물의 증식을 억제하는 항균작용을 한다. 또한 생체리듬 조절작용, 장내의 유용세균 증강기능, 중금속 및 방사선 물질 흡착, 배설, 및 세포의 재생촉진 및 노화방지기능을 가지고 있다.Chitosan as described above is effective in preventing circulatory diseases such as arteriosclerosis, heart disease because it has a cholesterol control function. In addition, since it has an immune system, the immune system is activated in the body to enhance immunity. In addition, since it has a bactericidal or antimicrobial effect, it binds to the cell membrane of the microorganism and thus has an antimicrobial effect. It also has biorhythm control, intestinal useful bacterium enhancer function, heavy metal and radioactive substance adsorption, excretion, and cell regeneration and anti-aging function.
상기와 같이 키토산을 수용성 및 불용성으로 제조한 후에, 키토산용액과 한약재 액상추출물을 혼화한다. 이렇게 혼화된 수용액에 양말을 침지시켜서 한약재와 키토산을 투입시킨다. 침지된 양말은 자연건조 또는 히터와 같은 가열수단을 이용하여 건조시킨다. 건조된 양말에는 한약재 추출물과 키토산이 함유되어서 성분을 외부로 투출시킨다. 이것이 본 발명의 제3단계이다. 도 2를 참고하면, 상기 제3단계에서는 한약재 추출성분과 키토산성분은 섬유(3)에 스며들게 된다.After preparing chitosan to be water-soluble and insoluble as described above, the chitosan solution and the herbal extracts are mixed. Soaking the sock in the mixed solution so added the herbal medicine and chitosan. The soaked socks are dried using a heating means such as natural drying or a heater. The dried socks contain herbal extracts and chitosan, and the ingredients are thrown out. This is the third step of the present invention. Referring to FIG. 2, in the third step, the herbal extract and chitosan components are permeated into the fibers 3.
이때 농축된 용액에 가열하여 양말이 변형되지 않을 정도의 온도로 섭씨 40도 - 100도 정도로 가온하면서 침지시키게 되면 농축도를 높인 상태로 직조된 양말의 섬유(3)에 용액의 침투가 가능하게 된다.At this time, when the solution is heated and soaked at 40 degrees centigrade to 100 degrees Celsius at a temperature such that the socks are not deformed, the solution can be infiltrated into the fibers 3 of the woven socks with high concentration.
제4단계는 한약재로부터 추출된 분말과 키토산분말을 코팅하는 단계이다.The fourth step is to coat the powder and chitosan powder extracted from the herbal medicine.
먼저 한약재를 추출하여 입자상태로 농축시켜 최소 500매쉬 이상으로 분쇄한 한약재의 농축분말과 역시 최소 500매쉬 이상으로 분쇄한 키토산의 총중량을 중량비 10%와, 코팅제 중량비15%와 용제 중량비 75%정도로 묽게 혼화한 다음 건조된 상태의 양말에 코팅 처리하여 한다. 코팅이 완료된 후에 제5단계로서 열을 가하여 소결시켜 피막층(4)을 형성하게 된다.First, the herbal medicines are extracted, concentrated to a particle state, and diluted to a minimum of 500 mesh. The concentrated powder of Chinese medicine and chitosan, which are ground to at least 500 mesh, are diluted 10% by weight, 15% by weight of the coating agent and 75% by weight of the solvent. After mixing, dry socks should be coated. After the coating is completed, the film is sintered by applying heat as a fifth step to form the coating layer 4.
상기 피막층(4)은 한약재와 키토산을 포함한 상태로 보관과 세탁 착용 등에 의하여도 오랜시간 약효를 유지시키기 위하여 양말의 한약 처리된 부위에 접착제와 농축분말을 묽게 혼화하여 처리한다. 이 때 용제가 증발되고 나면 한약재와 키토산의 농축분말 중량비 10%와 코팅제 중량비15%는 용제가 휘발하게 되면 한약재와 키토산의 중량비 30%와 코팅제 중량비70%가 되어 아주 얇은 상태로 코팅처리가 이루어지는데, 물에 녹지 않는 코팅제는 합성수지나 페인트계를 비롯하여 이외에도 다양한 여러 종류가 있으므로 자세한 설명은 생략한다.The coating layer (4) is treated by diluting the adhesive and concentrated powder in the herbal treatment site of the sock in order to maintain the long-term efficacy even in storage and laundry wearing in the state containing the herbal medicine and chitosan. At this time, after the solvent evaporates, the weight ratio of the concentrated powder of Chinese medicine and chitosan and the weight ratio of 15% of the coating agent are 30% by weight of the herbal medicine and chitosan and 70% of the weight of the coating agent. As coatings that are insoluble in water are various in addition to synthetic resins or paints, detailed descriptions thereof will be omitted.
또한 제4단계에서 형성된 피막층(4)은 제1 내지 제3단계에서 양말의 섬유(3)에 스며든 한약재와 키토산의 유출을 차단하는 역할을 하게 된다.In addition, the coating layer 4 formed in the fourth step serves to block the outflow of the herbal medicine and chitosan permeated into the fibers 3 of the socks in the first to third steps.
섬유의 유연성과 통기성 흡수성 등을 손상시키지 않고 피막층(4)에 농축 한약의 분말을 통하여 통로가 형성되어 흡수와 배수가 이루어지며, 사용으로 인하여 서서히 농축 분말이 방출되면서 섬유에 침투되어 있던 약이 농축분말이 위치하던구멍을 통하여 지속적으로 양말의 수명이 다할때 까지 방출되는 것이다. 또한 섬유(3)에 침투되어 있던 한약재와 키토산도 서서히 방출되어서 약효 및 키토산의 효과가 떨어지는 것을 방지한다.A passage is formed through the powder of concentrated herbal medicine in the coating layer 4 without impairing the flexibility and breathable absorbency of the fiber, so that absorption and drainage are achieved. Through the hole where the powder is located, it is continuously released until the end of the socks life. In addition, the herbal medicine and chitosan, which have penetrated into the fiber 3, are also gradually released to prevent the effect of the drug and chitosan from dropping.
상기와 같이 양말(1)의 코팅을 소결하여 피막층(4)을 형성한 후에, 원적외선 방사체를 양말(1)의 표면에 형성시키는 제6단계를 수행한다.After the coating of the socks 1 is sintered to form the coating layer 4 as described above, a sixth step of forming the far-infrared radiator on the surface of the socks 1 is performed.
원적외선 방사체로서는 맥반석 분말을 1,200℃에서 소성처리하여 미세입자로 분쇄하며 입자의 크기는 500메쉬(mesh)이상 되는 것이 바람직하다. 상기 맥반석 중량비 25%와 미세 분말상의 산화철 중량비 25% 합성수지 접착제 중량비 50%정도로 혼화하여 프린트형태나 실크인쇄 등의 방법으로 약 0.3-3mm 정도의 두께, 폭3-10mm 정도로 자성체 조성물(5)을 돌기형태로 인쇄한 다음 열에 의하여 접착(제7단계)시키게 된다.As the far-infrared emitter, it is preferable that the calcite powder is calcined at 1,200 ° C. to be pulverized into fine particles, and the size of the particles is 500 mesh or more. The magnetic body composition 5 is mixed with a thickness of about 0.3-3 mm and a width of about 3-10 mm by a method such as a printing form or silk printing by mixing with the ganban stone weight ratio 25% and the fine powder iron oxide weight ratio 25% synthetic resin adhesive weight ratio about 50%. After printing in the form, it is bonded by heat (seventh step).
종래 알려진 바와 같이 원적외선 방사체는 천연옥을 비롯하여 제올라이트 등을 비롯하여 수 없이 많은 종류의 것들이 있으나 그 중에서 맥반석은 원석보다 미세분말 입자에서 인체에 가장 유익한 원적외선 파장을 방출하고 있으며, 이것을 인체에 흡수시키면 탁월한 온열작용(체내온도 1.2~1.5℃ 상승)과 조직활성 에너지로 작용하여 미세혈관을 확장하고 혈액순환촉진 및 신진대사의 조정 등 매우 유익한 효능을 얻게 된다.As known in the art, far-infrared emitters include many kinds, including natural jade and zeolite, but among them, elvan emits far-infrared wavelengths which are most beneficial to the human body in fine powder particles than gemstones. (Increase the body temperature 1.2 ~ 1.5 ℃) and tissue activation energy to expand the microvascular vessels and gain very beneficial effects such as blood circulation promotion and metabolism adjustment.
여기서 접착제는 일반공지기술로 다양한 접착제와 접착시키는 기술들이 있으므로 상세한 설명은 생략하고 맥반석은 원적외선 방사율과 투과성이 높고 반영구적이며, 혈액순환을 촉진과 겨울에는 보온성과 여름에는 청량감을 가지게 되고 항균,항곰팡이, 유해 전자파로부터 보호, 탈취 작용이 이루어지는데, 원적외선은 중간매체 없이 직접적이고 순간적인 복사에너지를 전달한다.Here, the adhesive is a general publicly known technology, and there are techniques for bonding it with various adhesives, so the detailed description is omitted, and elvan has high far-infrared emissivity, high permeability, and is semi-permanent. It promotes blood circulation and keeps warmth in winter and refreshing in summer. It protects from harmful electromagnetic waves and deodorizes. Far-infrared rays transmit direct and instant radiant energy without intermediate.
원적외선 파장의 진동수가 인체분자의 진동수와 거의 같은 범위에 있기 때문에 인체에 투과되면 분자내에서 공명현상이 일어나 그 진동이 활발해지고 그러한 진동의 대부분이 열로 변하며, 일부에너지는 '활성화 에너지'로 작용한다.Since the frequency of the far-infrared wavelength is almost the same as the frequency of human molecules, when it is transmitted through the human body, resonance occurs in the molecule, causing the vibration to become active, and most of those vibrations turn into heat, and some energy acts as 'activation energy'. .
또한 심달력이 있어 피하에 깊이 충분한 영향을 미쳐서 체내 작용을 활성화시켜서 피하심층의 온도 상승, 미세혈관의 확장, 혈액 순환의 촉진, 몸 속의 노폐물 배출, 신진대사 촉진, 체액장애 일소 조직재생능력증가, 지각신경의 이상흥분억제, 자율신경 기능 조정효과 등의 의료적 효과도 발휘하는 것으로 잘 알려져 있다.In addition, it has a cardiac calendar, deeply affecting the subcutaneous effect to activate the body's action to increase the temperature of the subcutaneous layer, the expansion of microvascular vessels, the promotion of blood circulation, the excretion of waste products in the body, the promotion of metabolism, the increase of body tissues It is well known to have medical effects such as abnormal excitatory suppression of perceptual nerve and autonomic nervous system function.
그리고 자력이 인체에 미치는 영향에 대하여, 전통 동양의학의 경락(經絡)에 대한 이론을 토대로 한 이 요법은 발바닥에 많은 경혈이 위치하고 있어 이 경혈에 자기력을 가하여 경락과 연결된 장기조직의 자극과 원활한 혈액순환으로 인체의 활성화시키므로 부작용이 없이 건강한 상태를 유지시켜 줄수 있게 되는 것으로 자기는 효소를 활성화하며, 13000G의 자장을 가하면 소화효소인 트립신의 활동이 촉진되고, 4000G의 자장을 가하면 뇌신경세포의 정보전달에 밀접하게 관계되는 아세틸크린 에스에라제라는 효소가 활성화되는 것으로 알려져 있다.On the effect of magnetic force on the human body, this therapy based on the theory of Meridian in traditional Oriental medicine has a lot of acupuncture points on the sole of the foot. By activating the human body by circulation, it is possible to maintain a healthy state without side effects.It activates enzymes, and when the magnetic field of 13000G is applied, the activity of trypsin, which is a digestive enzyme, is stimulated, and the magnetic field of 4000G is used to transmit information of brain nerve cells. It is known that an enzyme called acetylclean eserase, which is closely related to, is activated.
그리고 자기는 음과 양, 두 종류가 있으며, 일반적으로 음자기는 진정효과를 나타내며 육체의 기능을 편안하게 유도하여 신진대사를 정상화시키는 반면, 양자기는 스트레스를 유발시키는 작용을 하고, 양자기에 오래 노출되면 신진대사가 방해를 받아 주위 조직이 산성화되고, 휴면중이던 세균들이 활성화되면서 여러가지 질환을 발생시키는 것으로 알려져 있다.In addition, there are two types of magnetism, yin and yang. In general, phonograms have a calming effect and induce the body's functions comfortably to normalize metabolism, while quantum groups act to induce stress. Prolonged exposure is known to interfere with metabolism, acidify surrounding tissues and activate dormant bacteria, causing various diseases.
자성체가 이방성이 형성되도록 자화 입력함에 있어, 착자기에 강한 DC전극을 가한 상태에서 자화처리를 하게 되면 전극의위치에 따라 상, 하로 일정한 방향의 자극을 띠게 되는데, 음자기측이 신체에 접촉하는 면에 위치하도록 자력을 입력하는 것이 바람직하다.In the magnetization input so that the magnetic material is formed anisotropically, if the magnetization process is applied while the strong DC electrode is applied to the magnetizer, the magnetic body is stimulated in a predetermined direction up and down according to the position of the electrode. It is desirable to enter the magnetic force to be located on the plane.
착자기로 부터 자성체를 자화시키는데, 자성체를 산화철을 사용할 경우 산화철 함량과 용적에 다소 차이가 있으나 산화철함량 25%, 직경 5mm, 높이 1.5mm의 상태에서 약 5.000가우스의 자력을 입력하였을 때 조성물이 띠고 있는 자력은 약 300가우스의 자력을 띠게 되었다.Magnetization of the magnetic material from the magnetizer. When iron oxide is used, the content and volume of iron oxide are slightly different. However, when the magnetic force of about 5.000 gauss is input at 25% of iron oxide, 5mm in diameter, and 1.5mm in height, The magnetic force present was about 300 gauss magnetic force.
이상과 같은 산화철에서의 경우 자력이 미약하여 일반적으로 사용하는데는 무방하나 치료용으로 보다 강한 자력을 띠게할 경우 잘 알려진 바와 같이 강한 자력을 띠는 희토류 원소인 세륨 Ce·사마륨 Sm과 코발트 Co 화합물(Ce Co6·Sm Co6·Sm2Co12)이나, 이트륨·코발트 화합물 YCo6 또는 네오디뮴 등이 사용될 수 있으며, 수십배의 자기력을 띠게 할수 있어 치료용으로 강력한 자력을 유지하기 위하여 사용될 수 있다.In the case of iron oxide as described above, the magnetic field is weak, so it is not generally used, but when it is stronger for therapeutic use, as is well known, the rare earth elements cerium Ce, samarium Sm and cobalt Co compounds ( Ce Co 6 Sm Co 6 Sm 2 Co 12), the yttrium cobalt compound YCo 6, or neodymium, and the like can be used, and can be used to maintain a strong magnetic force for treatment because it can take several tens of magnetic forces.
발에서 주로 발생되는 땀에는 지질(脂質)이나 단백질 등의 유기물이 비교적 많이 함유되어 있으며 분비된 신선한 땀에는 냄새가 없으나 피부 표면으로 이동하는 도중에 이들 유기물이 피부의 정상세균층(正常細菌叢)에 의해 분해되어 불쾌한 냄새로 변한다.The sweat, which occurs mainly on the feet, contains relatively high amounts of organic matter such as lipids and proteins, and the fresh secreted sweat has no odor.However, the organic matter is transferred to the normal bacterial layer of the skin while moving to the skin surface. Decomposes and turns into an unpleasant smell.
즉, 발에서 발생되는 악취는 주로 이 냄새에 기인하는데, 땀의 분비생성물로는 카프르산·카프로산·이소발레르산·부티르산 등의 저급지방산 및 메르캅탄·아민·암모니아 등으로 통기가 잘 되지 않는 상태에서 피부의 정상세균층에 의해서 분해되어 상당한 악취를 발생시킨다. 따라서 키토산 및 원적외선 발산물질의 살균, 항균 작용에 의하여 정상세균층이 제거되므로 악취발생이 감소되는 것이다.In other words, the odor generated from the foot is mainly caused by this smell, and sweat secretion products are poorly ventilated by lower fatty acids such as capric acid, caproic acid, isovaleric acid and butyric acid, and mercaptan, amine, and ammonia. If not, it is degraded by the normal bacterial layer of the skin, producing a significant odor. Therefore, the sterilization and antibacterial action of chitosan and far-infrared emanation material, the normal bacterial layer is removed, thereby reducing the occurrence of odor.
도 2에 도시된 돌기(2)는 반원형, 또는 타원형이며, 도 4에는 돌기(2)의 다른 실시예로서 중앙에 돌출부(2a)가 형성되고 그 주위에 함몰부(2b)가 형성된 변형 실시예가 표시되어 있다. 도 4의 돌기(2)는 발바닥과의 접촉시에 종래 돌기보다 더욱 강한 자극을 줌으로서 혈액순환을 촉진시키며 또한 공기순환에 도움을 주는 이점이 있다. 또한 공기와의 노출면적이 증가함으로서 키토산 또는 한약재로부터의 유익한 성분방출이 더욱 잘되는 효과가 있다.The projection 2 shown in FIG. 2 is semi-circular or elliptical, and in FIG. 4, another embodiment of the projection 2 is a modified embodiment in which a projection 2a is formed in the center and a depression 2b is formed around the projection 2. Is indicated. The projection 2 of FIG. 4 has an advantage of promoting blood circulation and also aiding in air circulation by giving a stronger stimulus than a conventional protrusion upon contact with the sole of the foot. In addition, by increasing the exposed area with air there is an effect that the beneficial component release from chitosan or herbal medicine is better.
돌기의 두께(H1) 및 폭(D1)은 약 0.3-3mm 정도의 두께, 폭3-10mm 정도로 하는 것이 바람직하다.The thickness H1 and the width D1 of the projections are preferably about 0.3-3 mm thick and 3-10 mm wide.
이와 같은 본 발명은, 양말(1)로 부터 한약의 성분이 지속적으로 방출되어 치료효과를 높이도록 하는 농축된 한약재와 키토산이 함유된 섬유(3)의 위에 역시 농축된 한약분말과 키토산분말이 혼화하여 이루어진 피막층(4)을 형성하고, 투과력이 좋은 원적외선과 자력을 발생시키는 자성체 조성물(5)은 다수개가 등간격으로 형성함으로서 유익한 효과가 발휘되는 것이다.In the present invention, the concentrated herbal medicine and chitosan powder are mixed on the concentrated herbal medicine and chitosan-containing fiber (3) to continuously release the components of the herbal medicine from the sock (1) to increase the therapeutic effect. By forming a coating layer 4 formed therein, and forming a plurality of magnetic composition 5 having good permeability with far infrared rays and magnetic force.
Claims (3)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR10-2001-0002749A KR100419478B1 (en) | 2001-01-12 | 2001-01-12 | Anti virus stockings and mehtod for manufacturing the stockings |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR10-2001-0002749A KR100419478B1 (en) | 2001-01-12 | 2001-01-12 | Anti virus stockings and mehtod for manufacturing the stockings |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20010044224A KR20010044224A (en) | 2001-06-05 |
KR100419478B1 true KR100419478B1 (en) | 2004-02-21 |
Family
ID=19704770
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR10-2001-0002749A KR100419478B1 (en) | 2001-01-12 | 2001-01-12 | Anti virus stockings and mehtod for manufacturing the stockings |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR100419478B1 (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20150272901A1 (en) * | 2014-03-27 | 2015-10-01 | Jie Gao | Garment Fabric |
CN105559157A (en) * | 2016-01-25 | 2016-05-11 | 邱定武 | Sole for treating fasciitis of toe tendons and making method thereof |
CN105661664A (en) * | 2016-01-25 | 2016-06-15 | 邱定武 | Stocking sole for treating gout and herbal preparation medicine of stocking sole |
US20220032086A1 (en) * | 2020-07-30 | 2022-02-03 | Albert Chin-Tang Wey | Ceramic module emitting far infrared radiation and specific low dose ionizing radiation |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20030043336A (en) * | 2001-11-28 | 2003-06-02 | 김성실 | Clothes using chitosan and flocking layer |
KR100838497B1 (en) * | 2007-04-04 | 2008-06-25 | 임달웅 | Anti-microbial fiber products |
PT2901874T (en) * | 2014-02-04 | 2016-12-07 | Gao Jie | Garment fabric |
KR200496112Y1 (en) * | 2021-12-15 | 2022-11-04 | 주식회사 빅엔빅 | Functional socks |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH05117902A (en) * | 1991-10-18 | 1993-05-14 | Momoki Nakagawa | Non-slip of socks |
JPH10292205A (en) * | 1997-04-10 | 1998-11-04 | Kanemasu:Kk | Socks |
KR20000027186A (en) * | 1998-10-27 | 2000-05-15 | 윤근수 | Textile having coated layer of abrasion resistance and production method thereof |
KR20000054491A (en) * | 2000-06-05 | 2000-09-05 | 김관배 | A antibiotic skilled have a socks |
KR20010017989A (en) * | 1999-08-16 | 2001-03-05 | 원인호 | Deodorant and antimicrobial composition and functional structure in socks bottom |
KR20010056219A (en) * | 1999-12-17 | 2001-07-04 | 김광배 | Method for Composition of Antibacterial Fiber Containing Artemisia Iwayomogi |
-
2001
- 2001-01-12 KR KR10-2001-0002749A patent/KR100419478B1/en not_active IP Right Cessation
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH05117902A (en) * | 1991-10-18 | 1993-05-14 | Momoki Nakagawa | Non-slip of socks |
JPH10292205A (en) * | 1997-04-10 | 1998-11-04 | Kanemasu:Kk | Socks |
KR20000027186A (en) * | 1998-10-27 | 2000-05-15 | 윤근수 | Textile having coated layer of abrasion resistance and production method thereof |
KR20010017989A (en) * | 1999-08-16 | 2001-03-05 | 원인호 | Deodorant and antimicrobial composition and functional structure in socks bottom |
KR20010056219A (en) * | 1999-12-17 | 2001-07-04 | 김광배 | Method for Composition of Antibacterial Fiber Containing Artemisia Iwayomogi |
KR20000054491A (en) * | 2000-06-05 | 2000-09-05 | 김관배 | A antibiotic skilled have a socks |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20150272901A1 (en) * | 2014-03-27 | 2015-10-01 | Jie Gao | Garment Fabric |
US9452214B2 (en) * | 2014-03-27 | 2016-09-27 | Jie Gao | Garment fabric |
CN105559157A (en) * | 2016-01-25 | 2016-05-11 | 邱定武 | Sole for treating fasciitis of toe tendons and making method thereof |
CN105661664A (en) * | 2016-01-25 | 2016-06-15 | 邱定武 | Stocking sole for treating gout and herbal preparation medicine of stocking sole |
US20220032086A1 (en) * | 2020-07-30 | 2022-02-03 | Albert Chin-Tang Wey | Ceramic module emitting far infrared radiation and specific low dose ionizing radiation |
Also Published As
Publication number | Publication date |
---|---|
KR20010044224A (en) | 2001-06-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN105107007B (en) | A kind of medical protective dressing of cation and preparation method thereof | |
CN103006923A (en) | Chinese medicinal liquid band-aid and preparation method | |
KR100419478B1 (en) | Anti virus stockings and mehtod for manufacturing the stockings | |
CN102302224A (en) | Nano-silver anionic far-infrared element fabric underwear for preventing and treating rheumatic arthritis | |
KR101656250B1 (en) | wristlets | |
CN105708254B (en) | Both effectiveness magnetic therapy sleeping bag | |
KR101649450B1 (en) | Skin wound healing composition | |
KR102160854B1 (en) | Bio-compatible absorbing member and sanitary napkin having the same | |
KR100346801B1 (en) | A antibiotic skilled have a socks | |
KR101894760B1 (en) | Functionality of the patches provided to emit the smell of herbs while having far-infrared radiation function | |
CN105520272B (en) | Prevent and treat the shoe-pad of the ringworm of the foot | |
KR102218296B1 (en) | Sanitary pad with enhanced antibacterial and deodorizing functions and manufacturing method thereof | |
KR200213939Y1 (en) | adhesive plaster with ball for radiating far-infrared ray | |
KR102075436B1 (en) | Sports muscle tape | |
KR102197760B1 (en) | Functional sports tape containing far-infrared radiation | |
WO2011124085A1 (en) | Healthcare insole with traditional chinese medicine | |
CN101317963B (en) | Traditional Chinese medicine for treating exogenous injury and ulcer and preparation method thereof | |
CN105029730A (en) | Healthcare spun bra with natural aroma of lysimachia foenum-graecum and producing method thereof | |
KR102488255B1 (en) | Enzyme composition for fry poultice | |
CN2649078Y (en) | Triple-effect paster Babu ointment | |
CN108796658A (en) | Intelligent thermoregulating meridian point physiotherapy clothes | |
KR20040049369A (en) | eye bandage skillea | |
KR100457436B1 (en) | A composition for poultice, a preparing method thereof and a use thereof | |
CN1256151C (en) | Musk medicated thread and its preparation method | |
CN103006843B (en) | Traditional Chinese medicine composition for treating diabetic foot and preparation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20120208 Year of fee payment: 9 |
|
FPAY | Annual fee payment |
Payment date: 20130208 Year of fee payment: 10 |
|
LAPS | Lapse due to unpaid annual fee |